Handa Pharmaceuticals Valuation
| 6620 Stock | TWD 51.90 1.10 2.08% |
At this time, the firm appears to be overvalued. Handa Pharmaceuticals retains a regular Real Value of NT$38.92 per share. The prevalent price of the firm is NT$51.9. Our model calculates the value of Handa Pharmaceuticals from evaluating the firm fundamentals such as Return On Equity of -41.47, price to book of 8.38 X, and Return On Asset of -27.2 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Handa Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Handa Pharmaceuticals is based on 3 months time horizon. Increasing Handa Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Handa stock is determined by what a typical buyer is willing to pay for full or partial control of Handa Pharmaceuticals. Since Handa Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Handa Stock. However, Handa Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 51.9 | Real 38.92 | Hype 51.9 | Naive 53.62 |
The intrinsic value of Handa Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Handa Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Handa Pharmaceuticals helps investors to forecast how Handa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Handa Pharmaceuticals more accurately as focusing exclusively on Handa Pharmaceuticals' fundamentals will not take into account other important factors: Handa Pharmaceuticals Total Value Analysis
Handa Pharmaceuticals is presently anticipated to have takeover price of 2.86 B with market capitalization of 5.66 B, debt of 13.36 M, and cash on hands of 315.09 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Handa Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.86 B | 5.66 B | 13.36 M | 315.09 M |
Handa Pharmaceuticals Investor Information
The company recorded a loss per share of 2.29. Handa Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to Handa Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Handa Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Handa Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Handa is to check how much profit was generated for every dollar of assets it reports. Handa Pharmaceuticals retains a negative application of resources of -27.2 (percent), losing NT$0.27 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Handa Pharmaceuticals shows how discouraging it operates for each dollar spent on its resources.Handa Pharmaceuticals Profitability Analysis
The company reported the revenue of 28.86 M. Net Loss for the year was (282.1 M) with profit before overhead, payroll, taxes, and interest of 68.71 M.About Handa Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Handa Pharmaceuticals. We calculate exposure to Handa Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Handa Pharmaceuticals's related companies.Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company also develops modified release dosage forms, such as orally disintegrating tablets, modified release orally disintegrating tablets, modified release suspension systems, and ophthalmic modified release systems. HANDA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct Handa Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Handa Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Handa Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Handa Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Handa Pharmaceuticals' revenue streams: Identify Handa Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Handa Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Handa Pharmaceuticals' growth potential: Evaluate Handa Pharmaceuticals' management, business model, and growth potential.
- Determine Handa Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Handa Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Handa Stock Analysis
When running Handa Pharmaceuticals' price analysis, check to measure Handa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Handa Pharmaceuticals is operating at the current time. Most of Handa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Handa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Handa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Handa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.